New U.S. travel restrictions & immediate next steps
Join Zachary Huffman and Josh Strongin where they discuss the latest US travel restrictions set to come into effect on June 9.
Keep up to date on recent Everbridge news, events, and content, including from our recent thought leadership events and articles.
Below are reports* † in which we’ve received recognition. In addition to those published here, we are also excited to be included in:
Join Zachary Huffman and Josh Strongin where they discuss the latest US travel restrictions set to come into effect on June 9.
In our latest Rapid Resilience Briefing, Zachary Nelson and Wyatt Kinney discuss the latest military developments and rising tensions in…
Register to learn how to improve your rapid crisis response, operational agility, and resilience to protect your business and drive continuous improvement.
Join us in Helsinki on May 21 for insights on resilience, continuity, and compliance from industry leaders with 20+ years' experience.
Join us as our subject matter expert, Sean McDevitt shares proven frameworks to navigate a challenging hurricane season.
The Everbridge Risk Intelligence Monitoring Center (RIMC) has designated the conflict between India and Pakistan a ‘special event’. This ensures…
*Forrester reports are available to Forrester subscribers or for purchase.
†Gartner reports are available for Gartner subscribers only
†GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
†Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.